Institutionellt ägande och fondägande - Säljare
Denna sida visar institutioner, fonder och större aktieägare som har minskat sina innehav eller stängt sina positioner under den senaste rapporteringsperioden. Röda rader indikerar stängda positioner. Klicka på länk-symbolen för att se hela transaktionshistoriken.
Uppgraderaför att låsa upp premiumdata.
| Fil Datum | Källa | Investerare | Typ | Genomsnittligt pris (beräknat) |
Aktier | Δ Aktier (%) |
Rapporterat värde (1000 USD) |
Δ Värde (%) |
Portföljallokering (%) |
|
|---|---|---|---|---|---|---|---|---|---|---|
| 2025-08-11 | 13F | Vanguard Group Inc | 0 | −100,00 | 0 | |||||
| 2025-05-15 | 13F | Woodline Partners LP | 0 | −100,00 | 0 | |||||
| 2025-08-28 | NP | GWX - SPDR(R) S&P(R) International Small Cap ETF | 6 956 | −1,57 | 122 | 10,91 | ||||
| 2025-08-14 | 13F | Sphera Funds Management Ltd. | 309 931 | −19,26 | 5 455 | −9,49 | ||||
| 2025-08-13 | 13F | Virtus Investment Advisers, Inc. | 5 457 | −36,81 | 96 | −28,89 | ||||
| 2025-08-14 | 13F | UBS Group AG | 3 743 | −49,75 | 66 | −43,97 | ||||
| 2025-08-14 | 13F | VR Adviser, LLC | 2 047 620 | −34,22 | 36 038 | −26,26 | ||||
| 2025-08-15 | 13F | Soleus Capital Management, L.P. | 732 968 | −10,03 | 12 900 | 0,86 | ||||
| 2025-06-27 | 13F/A | Goldman Sachs Group Inc | 0 | −100,00 | 0 | −100,00 | ||||
| 2025-08-14 | 13F/A | Barclays Plc | 2 796 | −2,27 | 0 | |||||
| 2025-08-14 | 13F | Ubs Asset Management Americas Inc | 55 377 | −18,96 | 975 | −9,14 | ||||
| 2025-07-30 | NP | SBIO - ALPS Medical Breakthroughs ETF | 35 675 | −14,90 | 592 | −11,11 | ||||
| 2025-08-14 | 13F | Cormorant Asset Management, LP | 1 454 660 | −0,80 | 25 602 | 11,20 | ||||
| 2025-05-14 | 13F | Virtus ETF Advisers LLC | 0 | −100,00 | 0 | |||||
| 2025-04-28 | NP | John Hancock Funds II - Health Sciences Fund Class NAV | 4 755 | −41,27 | 76 | −57,63 | ||||
| 2025-08-11 | 13F | Alps Advisors Inc | 29 398 | −19,75 | 517 | −10,09 | ||||
| 2025-08-14 | 13F | State Street Corp | 93 673 | −0,12 | 1 649 | 11,96 | ||||
| 2025-08-14 | 13F | Octagon Capital Advisors LP | 672 595 | −12,63 | 11 838 | −2,06 | ||||
| 2025-08-14 | 13F | Sofinnova Investments, Inc. | 585 532 | −1,33 | 10 305 | 10,62 | ||||
| 2025-07-24 | NP | FBIOX - Biotechnology Portfolio This fund is a listed as child fund of Fmr Llc and if that institution has disclosed ownership in this security, then these positions will not be double counted when calculating total shares and total value | 90 107 | −19,84 | 1 496 | −16,34 | ||||
| 2025-08-15 | 13F | Morgan Stanley | 59 772 | −20,69 | 1 052 | −11,16 | ||||
| 2025-05-05 | 13F | HealthInvest Partners AB | 0 | −100,00 | 0 | |||||
| 2025-08-11 | 13F | Patient Square Capital LP | 244 283 | −0,49 | 4 299 | 11,55 | ||||
| 2025-08-14 | 13F | Point72 Asset Management, L.P. | 37 612 | −28,46 | 662 | −19,88 | ||||
| 2025-08-14 | 13F | Bank Of America Corp /de/ | 16 023 | −45,14 | 282 | −38,43 |
